|
Oculus Innovative Sciences |
|
|
1129 North McDowell Blvd
Petaluma, CA 94954 USA
phone:(707) 283-0550
fax:(707) 283-0551
|
|
| Symbol |
OCLS |
| Exchange |
NASDAQ |
| Founded |
1999 |
| Employees |
76 |
|
|
| oculusis.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Oculus Innovative Sciences is a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn? Technology platform |
|
| Management |
| Hoji Alimi, Chief Executive Officer, President and Chairman of the Board; James Schutz, Chief Operating Officer, General Counsel, Corporate Secretary and Director; Robert Miller, Chief Financial Officer; Bruce Thornton, Executive Vice President; Robert Northey Ph.D, Director of Research and Development |
| |
|
|
|
|
|
|
|
| Keywords |
| Oculus, Microcyn, Vetericyn, Dermacyn, Hypochlorous Acid, Wound Care, Dermatology, Oral Care, |
|
|
|
| Description |
|
Oculus Innovative Sciences is a commercial biopharmaceutical company that designs,
produces and markets several safe and effective tissue care products based upon the
Microcyn Technology platform, which significantly reduces the need for antibiotics, all
the while reducing infections and accelerating healing. The Microcyn� supper-oxidized
Technology has been extensively studied, including peer-reviewed scientific publications,
and has been shown to impart significant wound healing benefits including, reduction
of inflammation, cure or improvement of infections and antimicrobial activity. The
company has developed several products that are commercially available world-wide,
including a dermatology hydrogel with itch and pain relief; a dermatology solution spray;
a post-surgical solution and negative-pressure wound therapy solution. The company�s
headquarters are in Petaluma, California, with operations in Latin America. |
|
| Products / Services |
Microcyn Wound Care is a super-oxidized solution for moistening, lubricating, leaning and debriding acute and chronic wounds including stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, post surgical wounds, burns, abrasions and minor irritations of the skin. Microcyn Wound HydroGel is for management of exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically debridement of wounds.
Microcyn Dermatology HydroGel is intended for management of wounds including itch and pain relief associated with dermal irritations, sores, injuries, and ulcers of dermal tissue.
Microcyn Dermatology Spray is to clean and aid debridement of intact skin, wounds and peri-wound tissue.
Microcyn Solution is for the irrigation and management via debridement of post-surgical wounds.
Microcyn? Negative-Pressure Wound Therapy Solution is for irrigation of wounds in conjunction with a variety of negative-pressure wound therapy systems.
And Vetericyn Wound Spray for animals, helps debride, rinse and eliminate odors in wounds and is scientifically designed for a wide variety of wounds, ulcers and abrasions.
Various products as well commercialized in India, Mexico, China, Europe and select Middle East countries.
|
|
| Technology / Differentiation |
| Microcyn has been studied for its clinical benefits and safety, a number of these findings peer-reviewed and published. These studies demonstrate that the Microcyn Technology delivers wound healing benefits, reduction of inflammation, cure or improvement of infection and antimicrobial activity |
|
| Market / Customers |
The company offers Microcyn-based Rx products via various regional and national distributors in the United States. It sells its products to hospitals, physicians, podiatrists and dermatologists; and other healthcare practitioners who are the caregivers to patients being treated for acute or chronic wounds, as well as those patients undergoing surgical procedures
|
|
| Strategy |
Maintain reduced burn while rapidly ramping revenues so as to achieve profitability at the earliest. In line with this, Oculus is focused on partnering with key companies in various niches including dermatology, wound care, animal healthcare,
|
|
| Funding |
| Company has sufficient cash and does not currently plan to fund raise. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members